We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chinese Cohort Study of Coronary Heart Disease (CCS-CHD)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2008 by Ministry of Science and Technology of the People´s Republic of China.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00745628
First Posted: September 3, 2008
Last Update Posted: September 3, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Ministry of Science and Technology of the People´s Republic of China
  Purpose
Construction of coronary heart disease cohort of more than 10000 patients in China. Investigation on current situation of secondary prevention of CHD will be carried out and the effect of physician training and patient education will be evaluated.

Condition
Coronary Heart Diseases

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Cross-Sectional Investigation of Secondary Prevention on Coronary Heart Disease and Generalization of Standardized Secondary Prevention in Chinese Coronary Heart Disease Patients

Resource links provided by NLM:


Further study details as provided by Ministry of Science and Technology of the People´s Republic of China:

Estimated Enrollment: 10000
Study Start Date: May 2008
Estimated Study Completion Date: December 2010
Estimated Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Detailed Description:
More than 40 hospitals of 16 provinces will enroll patients for this study. The study will include patients with diagnosed coronary heart disease. Investigators and all the physicians who will involve in daily care of CHD patients will have a brief training on guideline of secondary prevention in CHD and take a test on that. Questionnaires are used to evaluate patient's cognition of their diseases and knowledge on coronary heart disease. Patient education will be carried out during a 2 years follow up of all the patient enrolled before they are required to fill out another questionnaire. Physicians will also take a second test on secondary prevention of CHD at that time. Patients will take blood lipids and glucose test according to their physician's requirement.The effect of physician training and patient education will be evaluated by comparing the results of questionnaires and tests at the beginning of the study and in the end of the 2 years follow up.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Diagnosed coronary heart disease
Criteria

Inclusion Criteria:

  • Diagnosed coronary heart disease
  • Confirmed by coronary angiography;
  • Diagnosed myocardial infarction;
  • Typical symptom of ischemic chest pain with positive stress test;
  • Willing to sign an inform consent.

Exclusion Criteria

  • Patients won't sign an inform consent or will not comply with the follow up.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00745628


Contacts
Contact: Tao Hong, MD 86-10-66551122 ext 2229 dr_hongtao@163.com

Locations
China, Beijing
Peking University First Hospital Recruiting
Beijing, Beijing, China, 100034
Contact: Tao Hong    86-10-66551122 ext 2229    dr_hongtao@163.com   
Sponsors and Collaborators
Ministry of Science and Technology of the People´s Republic of China
Investigators
Principal Investigator: Tao Hong, MD Peking University First Hospital
  More Information

Responsible Party: YHuo,director, Peking University First Hospital
ClinicalTrials.gov Identifier: NCT00745628     History of Changes
Other Study ID Numbers: 2006BAI01A02-08
First Submitted: September 2, 2008
First Posted: September 3, 2008
Last Update Posted: September 3, 2008
Last Verified: May 2008

Keywords provided by Ministry of Science and Technology of the People´s Republic of China:
coronary heart disease
secondary prevention

Additional relevant MeSH terms:
Heart Diseases
Coronary Disease
Coronary Artery Disease
Myocardial Ischemia
Cardiovascular Diseases
Vascular Diseases
Arteriosclerosis
Arterial Occlusive Diseases